Vaxcyte, Inc.PCVXNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-448.08M
↓ 169% below average
Average (7y)
$-166.65M
Historical baseline
Range
High:$-17.21M
Low:$-448.08M
CAGR
+59.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-448.08M | -14.3% |
| 2023 | $-392.10M | -83.2% |
| 2022 | $-214.03M | -121.5% |
| 2021 | $-96.61M | -10.0% |
| 2020 | $-87.81M | -79.2% |
| 2019 | $-49.00M | -72.7% |
| 2018 | $-28.37M | -64.9% |
| 2017 | $-17.21M | - |